Articles by

Kate Knibbs

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly has sent cease-and-desist letters to hundreds of compounding pharmacies, telehealth companies, and medical spas making...

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating

Last week, the US Food and Drug Administration announced that tirzepatide is no longer in shortage. It...

Supplements Companies Are Cashing In on the Ozempic Wave

The supplement industry has a long, tangled history with the world of weight-loss products. Prior to the...

It’s Shockingly Easy to Buy Off-Brand Ozempic Online, Even If You Don’t Need It

The health care industry has never encountered anything quite like Ozempic before. First approved to treat Type...

The US Supreme Court Will Decide the Fate of Medication Abortion

The US Supreme Court decided Wednesday to hear a case challenging access to abortion pills in the...

Jennifer Doudna Believes Crispr Is for Everyone

It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This...

The Next Great Overdose-Reversing Drug Might Already Exist

Critics say the Schedule I classification is heavy-handed, based on fear rather than evidence. “It bypasses science,”...